ESCCA is very grateful for the support of the companies mentioned below. 

Interested in sponsoring ESCCA? Please click here for more information.



SYSMEX 18454 ESCCA2018 Logo 1to1 RGB RZ

Premier Sponsor at ESCCA 2019

About Sysmex Corporation

Sysmex Corporation is a world leader in clinical laboratory systems providing solutions for laboratory diagnostics, laboratory automation and clinical information systems. Our mission is to shape the advancement of healthcare by delivering technological leadership in diagnostic science and information tools that make a genuine difference to the health of people worldwide.

Sysmex is the global leader in haematology and a renowned specialist in haemostasis, urinalysis, and laboratory automation. As our expertise in the interdependency of disease and medical disciplines grows, we are expanding to cover other pressing areas such as oncology, flow cytometry, liquid biopsy and essential healthcare in resource-poor regions. We are starting a journey with flow cytometry laboratories by combining our 50 years’ experience and expertise to add automation into their workflow where it matters – to help laboratories make their workflow more efficient and deliver their services with absolute confidence in the results. Possible applications of our system, for example, include aiding the diagnosis of onco-haematological diseases or monitoring HIV disease progression.

Sysmex Europe GmbH (SEG), located near Hamburg, Germany, is a subsidiary of the Sysmex Corporation. From our Hamburg offices, we serve our affiliates, distributors and customers throughout Europe, the Middle East and Africa (EMEA). Of around 8,000 global staff across subsidiaries in North and Latin America, Europe, China, and Asia Pacific, 1,700 work in the EMEA region.

Everything we do is driven by our mission, which is supported by our corporate message Lighting the way with diagnostics.

For more information about Sysmex Europe, please visit



Beckman Coulter logo BCLS Horizontal resized

Premier Sponsor at ESCCA 2019

The history of Beckman Coulter is one of innovation, beginning with Dr. Arnold O. Beckman's solution for determining the precise measurement of pH in lemon juice—the acidimeter, or pH meter. From a small operation in the rear of a garage in Pasadena, California, to its recognition today as a world leader in clinical diagnostics and life science research, Beckman Coulter owes its success to three men of vision who revolutionized science and medicine: Arnold O. Beckman, Ph.D., and brothers Wallace and Joseph Coulter.

For 75 years, the world has turned to us for solutions, and we are proud to say we've solved many of them. Beckman Coulter's focus is to help create the world's most efficient laboratories that improve patient health and reduce the cost of care. Beckman Coulter Life Sciences is dedicated to developing and providing advanced technologies and equipment for research and discovery to explore new treatment methods. Our products include Centrifugation, Flow Cytometry, Liquid Handling, Genomic solutions and Particle Characterization which are implemented in all major areas of Life Sciences such as biology, biochemistry, biophysics, nanotechnology and molecular biology to simplify and automate existing processes in the lab.

For our top competitors, biomedical testing is one business among many; for Beckman Coulter, it is our sole focus. In today's market, we are one of the few participants with full capacity to design, develop, manufacture, sell and service our products.
Our vision: Advancing science through discovery – Our mission: Delivering innovative and trusted scientific solutions across the globe.
For more information please visit


bd color cmyk c tag EN 2 25

Platinum Sponsor at ESCCA 2019

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to better diagnose disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit